Patents by Inventor Snigdha Gaur

Snigdha Gaur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF SCREENING FOR COLORECTAL CANCER
    Publication number: 20210262038
    Abstract: The present invention relates generally to a method of determining one or more probabilities of respective classifications of a neoplasm into one or more neoplastic categories. More particularly, the present invention relates to a method of determining the probability of classification of a large intestine neoplasm into one or more categories selected from adenoma, stage I, stage II, stage III or stage IV by screening for changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP and/or CAHM. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 26, 2021
    Inventors: Lawrence Charles LAPOINTE, Susanne K. PEDERSEN, Rohan Kartin BAKER, Snigdha GAUR, Melissa THOMAS
  • METHOD OF SCREENING FOR COLORECTAL CANCER
    Publication number: 20210254169
    Abstract: The present invention relates generally to a method of determining one or more probabilities of respective classifications of a neoplasm into one or more neoplastic categories. More particularly, the present invention relates to a method of determining the probability of classification of a large intestine neoplasm into one or more categories selected from adenoma, stage I, stage II, stage III or stage IV by screening for changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP and/or CAHM. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 19, 2021
    Inventors: Lawrence Charles LAPOINTE, Susanne K. PEDERSEN, Rohan Kartin BAKER, Snigdha GAUR, Melissa THOMAS
  • Method of screening for colorectal cancer
    Patent number: 10941449
    Abstract: The present invention relates generally to a method of determining one or more probabilities of respective classifications of a neoplasm into one or more neoplastic categories. More particularly, the present invention relates to a method of determining the probability of classification of a large intestine neoplasm into one or more categories selected from adenoma, stage I, stage II, stage III or stage IV by screening for changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP and/or CAHM. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: March 9, 2021
    Assignee: CLINICAL GENOMICS PTY. LTD.
    Inventors: Lawrence Charles Lapointe, Susanne K. Pedersen, Rohan Baker, Snigdha Gaur, Melissa Thomas
  • METHOD OF SCREENING FOR COLORECTAL CANCER
    Publication number: 20150152505
    Abstract: The present invention relates generally to a method of determining one or more probabilities of respective classifications of a neoplasm into one or more neoplastic categories. More particularly, the present invention relates to a method of determining the probability of classification of a large intestine neoplasm into one or more categories selected from adenoma, stage I, stage II, stage III or stage IV by screening for changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP and/or CAHM. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis.
    Type: Application
    Filed: May 17, 2013
    Publication date: June 4, 2015
    Applicant: CLINICAL GENOMICS PTY. LTD.
    Inventors: Lawrence Charles Lapointe, Susanne K. Pedersen, Rohan Baker, Snigdha Gaur, Melissa Thomas